Kangmei Pharmaceutical: Plans to transfer 100% equity and related assets of its wholly-owned subsidiary Shanghai Deda Tang Guoyao to Shanghai Kangmei Pharmaceutical for 1 RMB.

2026-04-10 19:26:06

Kangmei Pharmaceutical announced that it plans to transfer 100% equity and related assets of its wholly-owned subsidiary Shanghai Deda Tang Guoyao Co., Ltd. to Shanghai Kangmei Pharmaceutical Co., Ltd. at a price of 1 RMB.
After this transfer is completed, Kangmei Pharmaceutical will no longer hold the equity or related assets of Deda Tang Guoyao, and Deda Tang Guoyao will no longer be included in Kangmei Pharmaceutical’s consolidated financial statements.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes